H.R. 8857119th CongressReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Next GEN Act of 2026

Introduced: May 15, 2026

Latest action: May 15, 2026

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Congress.gov Bill Record ↗

Primary Sponsors

Cosponsors

Recorded Actions

Linked Votes

Plain-English AI Summary

What this bill means

Generated from the official bill text to make the legislation easier to understand.

Not Generated

A plain-English AI summary has not been generated for this bill yet.

Official Summary

Official legislative summary associated with this bill.

No official summary is currently available.

Primary Sponsors

Members listed as primary sponsors of this legislation.

Joseph D. Morelle

Democrat • New York • District 25

Primary Sponsor

May 15, 2026

Cosponsors

Members who joined this legislation as cosponsors.

August Pfluger

Republican • Texas • District 11

Original Cosponsor

May 15, 2026

View profile →

Donald G. Davis

Democrat • North Carolina • District 1

Aug 27, 2026

View profile →

Recorded Actions

Official legislative actions recorded for this measure.

H11100May 15, 2026

Official source ↗

Intro-HMay 15, 2026

Introduced in House

Official source ↗

Linked Votes

Roll-call votes associated with this legislation.

No roll-call votes are currently linked to this bill.

Lobbying Activity

Federal lobbying disclosures that explicitly identify H.R. 8857. These records show reported lobbying involving the legislation; they do not establish that every member of Congress, sponsor, or voter was personally contacted.

MERCK & CO., INC

Registrant: TIBER CREEK GROUP

2nd Quarter (Apr 1 - June 30)

Jul 19, 2026

Reported lobbying issue

Medicare/Medicaid: Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 8857 - Next GEN Act of 2026. Trade (domestic/foreign): Issues related to intellectual property protections. Health Issues: Issues related to immunization policy.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

Discussion notificationsSign in to subscribe

No comments yet. Start the conversation.